ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Cash from investing

Sumitomo Pharma Co., Ltd. (4506)

Market cap
¥581.7B
P/E ratio
8.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 202622,549-77.40%
Mar 31, 202599,754+201.96%
Mar 31, 202433,036-36.98%
Mar 31, 202352,419-386.79%
Mar 31, 2022-18,278-305.95%
Mar 31, 20218,875-102.84%
Mar 31, 2020-312,684+792.13%
Mar 31, 2019-35,049+112.12%
Mar 31, 2018-16,523-72.34%
Mar 31, 2017-59,729-475.96%
Mar 31, 201615,887-32.24%
Mar 31, 201523,447

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat